Search results for: “FDA Approval”
-
Lonza expands Bioconjugation facility and announces approval of third commercial ADC
•
BASEL, SWITZERLAND: Lonza has announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with…
-
RUA Life Sciences has acquired Analytic Biosurgical Solutions (Abiss)
•
LONDON: RUA Life Sciences (AIM: RUA) has acquired the entire issued share capital of Analytic Biosurgical Solutions SAS,…
-
HoneyNaps secures a $11.6 million Series B investment
•
BOSTON: HoneyNaps, an industry-leading South Korean company in artificial intelligence (AI) sleep data analysis, has closed its series…
-
ThinkSono secures £2.1M in oversubscribed funding to advance AI ultrasound technology
•
ThinkSono has successfully closed an oversubscribed funding round, raising £2.1 million. The round, led by id4 ventures and…
-
Johnson & Johnson MedTech acquires Laminar Inc. for an upfront $400 million
•
NEW BRUNSWICK: Johnson & Johnson MedTech, a division of Johnson & Johnson that focuses on medical intervention solutions,…
-
Artrya CEO outlines plans to launch AI-powered heart disease solution in US and Australia
•
SYDNEY, AUSTRALIA: Artrya Limited, a company that develops artificial intelligence (AI) solutions for heart disease diagnosis and treatment,…
-
Inari Medical to acquire LimFlow for up to $415 million
•
Inari Medical, a company that develops devices for venous and other diseases, has agreed to buy LimFlow, a…
-
PAG agrees to buy controlling stake in Australian Venue Co from KKR
•
PAG, a leading Asia Pacific alternative investment firm, has agreed to buy the controlling stake in Australian Venue…
-
Dr Howie McKibbon appointed CEO of Botanix Pharmaceuticals
•
SYDNEY, AUSTRALIA: Botanix Pharmaceuticals Limited (ASX: BOT), a company that specializes in clinical dermatology, has announced the promotion…
-
Polarean Imaging appoints new CEO as it enters commercial phase
•
LONDON, UK: Polarean Imaging plc (AIM: POLX), the medical imaging company, has announced that it has appointed Christopher…
-
Cyclopharm Limited has acquired DuPharma ApS, based in Copenhagen
•
SYDNEY, AUSTRALIA: Cyclopharm Limited (ASX: CYC) has acquired DuPharma ApS, based in Copenhagen, Denmark. DuPharma is a third-party…
-
Hikma Pharmaceutical agrees to buy Custopharm for $375 million
•
Hikma Pharmaceutical , Custopharm , acquire, Waster Street Healthcare Partners, LONDON, UK: Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.